BMO's initiation adds a conservative bullish view to a crowded consensus, but the insider selling and 62.6% short interest create significant divergence. Traders should watch for a catalyst (e.g., earnings beat or product announcement) that could trigger a short squeeze, the setup is binary.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 21 $473.25entry
- T+1 · 3mo ago −3.49%α −3.19% · $456.75
- T+5 · 3mo ago −1.62%α −2.09% · $465.58
- T+20 · 8w ago +30.06%α +30.59% · $615.52
- T+60 · 13h ago +6.56%α +9.92% · $504.28
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
BMO Capital initiated coverage on AMD with an Outperform rating and a $550 price target, implying 17% upside from the current $469.46. The firm has a 53% accuracy rate on 1,841 calls with an average return of 2.3%, placing it in the average tier. Consensus is heavily bullish: 48 of 58 analysts rate it Buy (83%), 10 Hold, 0 Sell. The mean target is $614.43, median $610, high $1,250, low $365. BMO's $550 target is below the mean, a relatively conservative entry point. EPS revisions are strongly positive: 30-day revisions up 25 vs 3 down for the current quarter, and 33 vs 2 down for next year. Insider selling by President Su Lisa T on Aug 18 totaled ~$2.79M across five trades, a notable bearish signal that diverges from the bullish analyst initiation. Institutional flows are mixed: Wellington added 33.9%, JPMorgan added 66.2%, but Capital Research trimmed 37.3%. Short interest is elevated at 62.6% of float, suggesting heavy bearish positioning. Bottom line: BMO's initiation adds a new bullish voice to a crowded consensus, but the insider selling and high short interest create a tug-of-war, traders should watch for a catalyst to break the stalemate.
Impact Score
Consensus & Targets
Consensus is 83% Buy (16 strong buy, 32 buy), 17% Hold (10 hold), 0% Sell. 58 analysts cover the stock. The direction is overwhelmingly bullish, though the high number of holds suggests some caution at current levels.
Mean target $614.43, median $610, high $1,250, low $365. Current price $469.45 implies 30.9% upside to the mean. BMO's $550 target is 10.5% below the mean, making it one of the more conservative bullish calls. The wide range ($365 to $1,250) reflects deep disagreement on valuation.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-21 | BMO Capital | initiate | Outperform | $550.00 |
| 2026-08-06 | Argus Research | maintain | Buy | No target |
| 2026-08-06 | Rosenblatt | maintain | Buy | $700.00 |
| 2026-08-05 | DA Davidson | maintain | Buy | No target |
| 2026-08-05 | Morgan Stanley | maintain | Equal-Weight | $465.00 |
| 2026-08-05 | JP Morgan | maintain | Neutral | No target |
| 2026-08-05 | Truist Securities | maintain | Buy | $594.00 |
| 2026-08-05 | Wells Fargo | maintain | Overweight | $700.00 |
| 2026-08-05 | RBC Capital | reiterate | Sector Perform | $540.00 |
| 2026-08-05 | Wedbush | reiterate | Outperform | $600.00 |
30-day analyst activity shows 1 upgrade (this initiation) and 0 downgrades. EPS revisions are strongly positive: current quarter revisions up 22 in 7 days, 25 in 30 days vs 3 down; next year revisions up 29 in 7 days, 33 in 30 days vs 2 down. Estimates are being revised higher across all timeframes.
Firm Track Record: BMO Capital
BMO Capital accuracy: 53% on 1841 calls | avg return: 2.3%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Bernstein | 100% | 2/2 | 65.5% | top tier |
| Raymond James | 100% | 2/2 | 58.8% | top tier |
| Melius Research | 100% | 3/3 | 8.3% | top tier |
| Wolfe Research | 100% | 2/2 | -11.5% | top tier |
| HSBC | 83% | 5/6 | 17.6% | top tier |
| Barclays | 71% | 5/7 | 21.8% | top tier |
| Goldman Sachs | 67% | 2/3 | 4.1% | top tier |
| Stifel | 60% | 3/5 | 25.5% | above average |
| Mizuho | 57% | 8/14 | 12.3% | above average |
| B of A Securities | 55% | 6/11 | 21% | above average |
BMO Capital has a 53% accuracy rate on 1,841 scored calls with a 2.3% average return, average-tier performance. Top-tier firms on AMD include Bernstein (100% on 2 calls, +65.5% avg return) and Raymond James (100% on 2, +58.8%). BMO's initiation is not from a top-tier firm, reducing its standalone significance.
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $1.93 | $1.72 to $2.03 | $13.0B | ↑22 ↓0 |
| +1y | $15.47 | $10.77 to $19.96 | $87.3B | ↑29 ↓0 |
| +1q | $2.65 | $1.93 to $3.22 | $16.1B | ↑17 ↓0 |
| 0y | $7.56 | $7.00 to $8.20 | $50.8B | ↑28 ↓0 |
Cross-Platform Signals
Insider trades show President Su Lisa T sold ~$2.79M on Aug 18, a bearish signal that diverges from the bullish initiation. Congressional activity is mixed: one buy (Rick Allen, $1k-$15k) and two sells (Dan Newhouse, $1k-$15k; Tony Wied, $100k-$250k). Institutional changes are mixed: Wellington (+33.9%), JPMorgan (+66.2%), Norges Bank (new $13.6B position) are bullish; Capital Research (-37.3%) is bearish. Short interest is very high at 62.6% of float, indicating heavy bearish positioning that could fuel a squeeze on positive news.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
46 reports on AMD
11 of 17 bullish or bearish reports moved the stock their way by T+5. Best: +44.80% at T+60 after the Apr 24, 2026 report. 14 of 17 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 3/10 Entry $504.60 Now $504.28 −0.06% settles Nov 24
- Nov 16, 2026today 8-K/A Neutral 3/10 Entry $506.51 Now $504.28 −0.44% settles Nov 23
- Nov 16, 2026today Press Release Neutral 4/10 Entry $507.11 Now $504.28 −0.56% settles Nov 23
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $585.30 Now $504.28 −13.84% settles Nov 19
- Nov 3, 202613d ago 8-K Bullish 7/10 No price data
- Nov 3, 202613d ago Press Release Bullish 7/10 Entry $488.78 to $552.90 Now $504.28 +3.17% ▲ +13.12% +14.03% vs SPY
- Oct 27, 202620d ago Press Release Bullish 6/10 Entry $560.26 to $483.90 Now $504.28 −9.99% ▼ −13.63% −11.64% vs SPY
- Oct 22, 202624d ago Institutional Cluster Mixed 3/10 Entry $516.79 to $504.80 Now $504.28 −2.42% ▼ −2.32% −1.76% vs SPY
- Oct 21, 202627d ago PTAB Trial Neutral 3/10 Entry $507.93 to $562.50 Now $504.28 −0.72% ▲ +10.74% +10.04% vs SPY
- Oct 20, 202628d ago PTAB Trial Bullish 5/10 Entry $552.72 to $560.26 Now $504.28 −8.76% ▲ +1.36% +1.47% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers